Company Filing History:
Years Active: 2021-2025
Title: The Innovative Contributions of Jayaraman Kannappan
Introduction
Jayaraman Kannappan is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on the development of innovative processes and formulations that enhance the efficacy and safety of pharmaceutical compounds.
Latest Patents
One of his latest patents is titled "Process for the purification of methylene blue." This application provides a method for producing methylene blue that includes steps such as providing a reaction mixture with one or more methylene blue intermediates, precipitating metal from the reaction mixture, and producing crude methylene blue. The resulting compounds have low impurities, with a purity greater than about 97%, and a total metal content no greater than 77 ppm. Additionally, formulations containing such compounds are also provided.
Another significant patent is "Ready to use injectable formulations of melphalan and processes for preparation thereof." This application presents stable, ready-to-use injectable formulations of melphalan. The methods described ensure that these formulations are easy to administer without the need for any reconstitution step, while also maintaining a desirable solubility, stability, and safety profile.
Career Highlights
Jayaraman Kannappan has worked with several companies throughout his career, including Rk Pharma Solutions LLC and Rk Pharma Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to pharmaceutical formulations.
Collaborations
He has collaborated with notable colleagues such as Ravishanker Kovi and Shivnath Sahebrao Patil. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Jayaraman Kannappan's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving drug formulations and processes. His work continues to impact the industry positively, paving the way for safer and more effective pharmaceutical solutions.